Lead Speaker: Isha Mehta, MPH – Regeneron Pharmaceuticals
### @@@ Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals ### 1063148###Speaker###Senior Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###Speaker: Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Syd Phillips, MPH – Transom Development ### 2325356###Speaker######Transom Development###Speaker: Syd Phillips, MPH – Transom Development
### @@@ Enriqueta Vallejo-Yagüe, PhD, Pharm – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland ### 2325322###Speaker###Advanced Postdoc and Team Lead###Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland###Speaker: Enriqueta Vallejo-Yagüe, PhD, Pharm – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
### @@@ Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands ### 1062870###Speaker###PhD Researcher###PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands###Speaker: Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
### he/him/his @@@ Tamar Lasky, PhD (she/her/hers) – Retired ### 2325357###Speaker###Retired###Retired###Speaker: Tamar Lasky, PhD (she/her/hers) – Retired
### she/her/hers @@@ Eileen Dareng, MD, PhD – Astra Zeneca ### 2325328###Speaker###Director Safety Epidemiology###Astra Zeneca###Speaker: Eileen Dareng, MD, PhD – Astra Zeneca
### @@@ Denise Umuhire – European Medicines Agency ### 1994155###Speaker######European Medicines Agency###Speaker: Denise Umuhire – European Medicines Agency
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656### Co-Author###Head of Real-World Evidence###European Medicines Agency###Co-Author: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Elizabeth Russell, PhD, MSc – Merck & Co., Inc ### 2325358### Co-Author###Principle Scientist###Merck & Co., Inc###Co-Author: Elizabeth Russell, PhD, MSc – Merck & Co., Inc
###Presenting Author: Hui Feng, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Francesco Ronzano – IQVIA ### 2325220###Co-Author######IQVIA###Co-Author: Francesco Ronzano – IQVIA
### @@@ Jude LaFleur – IQVIA ### 2325217###Co-Author######IQVIA###Co-Author: Jude LaFleur – IQVIA
### @@@ Matthew L. Garber, n/a – IQVIA ### 2325218###Co-Author###Senior AI Engineer###IQVIA###Co-Author: Matthew L. Garber, n/a – IQVIA
### @@@ Rodrigo de Oliveira, PhD – IQVIA ### 2325219###Co-Author###Senior AI Engineer###IQVIA###Co-Author: Rodrigo de Oliveira, PhD – IQVIA
### @@@ Katharine Roth – IQVIA ### 2325234###Co-Author######IQVIA###Co-Author: Katharine Roth – IQVIA
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Co-Author###Associate Director of Epidemiology###IQVIA###Co-Author: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers @@@ Jay Nanavati – IQVIA ### 2325215###Co-Author######IQVIA###Co-Author: Jay Nanavati – IQVIA
### @@@ Khaldoun Zine El Abidine, M.A.Sc. – IQVIA ### 2325216###Co-Author###Senior Director of Technology###IQVIA###Co-Author: Khaldoun Zine El Abidine, M.A.Sc. – IQVIA
###Moderator: Lina Titievsky, PhD MPH – GSK
### @@@ Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands ### 1062870###Moderator###PhD Researcher###PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands###Moderator: Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
### he/him/hisPresenting Author: Søren Riis Petersen, BSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Kasper Bonnesen, MD, PhD (he/him/his) – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1991650###Co-Author###Postdoc###The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Kasper Bonnesen, MD, PhD (he/him/his) – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### he/him/his @@@ Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1358234###Co-Author###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Erik Lerkevang Grove, MD, PhD – Department of Cardiology, Aarhus University Hospital ### 2325556###Co-Author######Department of Cardiology, Aarhus University Hospital###Co-Author: Erik Lerkevang Grove, MD, PhD – Department of Cardiology, Aarhus University Hospital
### @@@ Morten Schmidt, MD, PhD, DMSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1360426###Co-Author######The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Morten Schmidt, MD, PhD, DMSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###Presenting Author: David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson
### he/him/his @@@ Justin Bohn, ScD – Johnson & Johnson ### 1991161###Co-Author###Associate Director, Epidemiology###Johnson & Johnson###Co-Author: Justin Bohn, ScD – Johnson & Johnson
### @@@ Michael Maher – Johnson & Johnson ### 2325320###Co-Author######Johnson & Johnson###Co-Author: Michael Maher – Johnson & Johnson
### @@@ Amin Yakubu – Johnson & Johnson ### 2325321###Co-Author######Johnson & Johnson###Co-Author: Amin Yakubu – Johnson & Johnson
### @@@ Dmytro Dymshyts – Johnson & Johnson ### 1994088###Co-Author######Johnson & Johnson###Co-Author: Dmytro Dymshyts – Johnson & Johnson
### @@@ Azza Shoaibi, PhD, MPH – Johnson & Johnson ### 1360292###Co-Author###Director###Johnson & Johnson###Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson
###Presenting Author: Grace Hsu, MSc – Cytel
###Presenting Author: Mackenzie Herzog, PhD, MPH – IQVIA
### @@@ Kristin Shiue, PhD, MPH – IQVIA ### 2331015###Co-Author######IQVIA###Co-Author: Kristin Shiue, PhD, MPH – IQVIA
### @@@ Rebecca Lee, PhD, MPH – IQVIA ### 2331016###Co-Author######IQVIA###Co-Author: Rebecca Lee, PhD, MPH – IQVIA
### @@@ Leigh Weiss, PT, DPT, MS, ATC – New York Giants ### 2331018###Co-Author######New York Giants###Co-Author: Leigh Weiss, PT, DPT, MS, ATC – New York Giants
### @@@ Tyler Williams, MS, ATC – Minnesota Vikings ### 2331019###Co-Author######Minnesota Vikings###Co-Author: Tyler Williams, MS, ATC – Minnesota Vikings
### @@@ Allen Sills, MD, FACS – NFL ### 2330855###Co-Author######NFL###Co-Author: Allen Sills, MD, FACS – NFL
### @@@ Christina D. Mack, PhD, FISPE – IQVIA ### 2326929###Co-Author###Chief Scientific Officer###IQVIA###Co-Author: Christina D. Mack, PhD, FISPE – IQVIA
###Lead Speaker: Anne Broe, MD PhD (she/her/hers) – IQVIA, London, UK
### she/her/hers @@@ Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1360167###Speaker###Deputy Director for Safety###Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###Speaker: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Sydney K. Willis, PhD – IQVIA ### 1723609###Speaker###Epidemiologist###IQVIA###Speaker: Sydney K. Willis, PhD – IQVIA
### @@@ Eileen Dareng, MD, PhD – Astra Zeneca ### 2325328###Speaker###Director Safety Epidemiology###Astra Zeneca###Speaker: Eileen Dareng, MD, PhD – Astra Zeneca
### @@@ Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Speaker###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###Speaker: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
###